In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
no speaker photo
Speaker
Takashi Unoki

Saiseikai Kumamoto Hospital, Kumamoto (Japan)

Specialities : Interventional Cardiology , Acute Cardiac Care

8 presentations from this speaker

Growth differentiation factor-15 and mortality in suspected or known coronary heart disease patients with diabetes: a subanalysis of the ANOX study

Congress : ESC Congress 2019

  • Session : Coronary artery disease - Epidermiology, prognosis and outcome
  • Speaker : T Unoki (Kumamoto,JP)

Vascular endothelial growth factor-C and mortality in patients with suspected but no history of coronary heart disease: a subanalysis of the ANOX study

Congress : ESC Congress 2019

  • Session : Coronary Artery Disease - Epidemiology, Prognosis, Outcome
  • Speaker : T Unoki (Kumamoto,JP)

Serum vascular endothelial growth factor-C levels inversely associated with the risk of atherosclerotic cardiovascular events following drug-eluting stent implantation

Congress : ESC Congress 2015

  • Session : Short and long-term outcomes after PCI and non-coronary intervention
  • Speaker : T Unoki (Kumamoto,JP)

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are